With the race for the White House tightening, markets could be in for a bumpy road ahead in the near term.
Jim Cramer shares his take on various caller stocks, including this pharma stock caught in the political pricing war.
Jim Cramer eyed the biotechs after Sarepta Therapeutics rally, and found another attractive spec that could boost portfolios.
CNBC's Jim Cramer shares his take on Proctor & Gamble, Clorox and more on the market's "the worst day since June," as well as his thoughts on the Fed.
Jim Cramer revealed what stock pitfalls might be lurking in the market.
Jim Cramer revealed what stock pitfalls might be lurking in the economy.
As the battle for the aisles of the supermarket continue, Jim Cramer is on high alert to avoid the most treacherous group in the market.
The Federal Reserve's decision to raise interest rates — or not — may have no bearing on a trade that's attracting lots of investors.
Jim Cramer spoke with top executives on fashion in sports, the shining stars in retail and beating the competition through innovation.
Jim Cramer revealed the standouts of earnings season, and what groups to focus on moving forward.
Jim Cramer analyzes the consumer packaged goods space with Clorox CEO Benno Dorer, discussing key strategy components and innovation within the company.
CNBC's Bob Pisani looks ahead at what's moving in early morning trading including Clorox earnings and retail stocks that in the red.
The household products maker reported earning of $1.26 per share, two cents a share below estimates.
Some of the names on the move ahead of the open.
Jim Cramer built a case for how infrastructure spending could impact this materials company’s earnings.
The "Fast Money" traders said that there may still be some opportunities left in the market.
The "Fast Money" Traders run through some stock buys and some passes.
Michael Vogelzang, Boston Advisors, and David Nelson, Belpointe Asset Management, offer their opinion on household product stocks.
Jim Cramer says that as stocks bounce back, investors will be on the hunt for high-growth opportunities.
CNBC's Jim Cramer gives investors his take on what to buy and when in these uncertain markets.